Citations (165)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Hila Bufman, Rami Eliakim, Noam Tau & Michal Marianne Amitai. (2021) Magnetic resonance enterography in Crohn’s disease patients: current state of the art and future perspectives. Expert Review of Medical Devices 18:7, pages 657-667.
Read now
Read now
Anders Rönnblom & Urban Karlbom. (2020) Clinical course of Crohn’s disease in a population-based cohort in Uppsala County followed for 10 years. Scandinavian Journal of Gastroenterology 55:11, pages 1301-1307.
Read now
Read now
Cátia Arieira, Tiago Cúrdia Gonçaves, Francisca Dias de Castro, Maria João Moreira & José Cotter. (2018) Clinical course in Crohn’s disease: factors associated with behaviour change and surgery. Scandinavian Journal of Gastroenterology 53:10-11, pages 1222-1227.
Read now
Read now
Gert Huppertz-Hauss, Marte Lie Høivik, Lars-Petter Jelsness-Jørgensen, Randi Opheim, Magne Henriksen, Ole Høie, Øistein Hovde, Iril Kempski-Monstad, Inger Camilla Solberg, Jørgen Jahnsen, Geir Hoff, Bjørn Moum & Tomm Bernklev. (2017) Fatigue in a population-based cohort of patients with inflammatory bowel disease 20 years after diagnosis: The IBSEN study. Scandinavian Journal of Gastroenterology 52:3, pages 351-358.
Read now
Read now
Anders Rönnblom, Tommy Holmström, Urban Karlbom, Hans Tanghöj, Mari Thörn & Daniel Sjöberg. (2017) Clinical course of Crohn’s disease during the first 5 years. Results from a population-based cohort in Sweden (ICURE) diagnosed 2005–2009. Scandinavian Journal of Gastroenterology 52:1, pages 81-86.
Read now
Read now
Anders Rönnblom, Tommy Holmström, Hans Tanghöj, Urban Karlbom, Mari Thörn & Daniel Sjöberg. (2016) Low colectomy rate five years after diagnosis of ulcerative colitis. Results from a prospective population-based cohort in Sweden (ICURE) diagnosed during 2005–2009*. Scandinavian Journal of Gastroenterology 51:11, pages 1339-1344.
Read now
Read now
Einar S. Björnsson & Anders Ekbom. (2015) Scandinavian epidemiological research in gastroenterology and hepatology. Scandinavian Journal of Gastroenterology 50:6, pages 636-648.
Read now
Read now
Rebecca Hein, Ingrid Köster, Elfriede Bollschweiler & Ingrid Schubert. (2014) Prevalence of inflammatory bowel disease: estimates for 2010 and trends in Germany from a large insurance-based regional cohort. Scandinavian Journal of Gastroenterology 49:11, pages 1325-1335.
Read now
Read now
Claire Smart & Christian P Selinger. (2014) The cost–effectiveness of infliximab in Crohn’s disease. Expert Review of Pharmacoeconomics & Outcomes Research 14:5, pages 589-598.
Read now
Read now
Ulrike Strauch & Jürgen Schölmerich. (2010) Emerging drugs to treat Crohn's disease. Expert Opinion on Emerging Drugs 15:2, pages 309-322.
Read now
Read now
Articles from other publishers (155)
Bernd Bokemeyer, Sandra Plachta-Danielzik, Romina di Giuseppe, Philipp Efken, Wolfgang Mohl, Martin Hoffstadt, Thomas Krause, Axel Schweitzer, Elisabeth Schnoy, Raja Atreya, Niels Teich, Leo Trentmann, Robert Ehehalt, Petra Hartmann & Stefan Schreiber. (2024) Real-World Effectiveness of Vedolizumab vs Anti-TNF in Biologic-naïve Crohn’s Disease Patients: A 2-year Propensity-score-adjusted Analysis from the VEDOIBD-Study. Inflammatory Bowel Diseases 30:5, pages 746-756.
Crossref
Crossref
Wolfgang Kruis, Bernd Bokemeyer, Petra Jessen, Mark Hoesl, Michael Mroß, Julia Morgenstern, Birgitta Reimers, Nike Müller-Grage & Ludger Leifeld. (2024) Prospective Evaluation of the Prediction Score for a Mild Course of Crohn’s Disease (PreMiCC) in Newly Diagnosed Patients With Crohn’s Disease: The PROGNOS Study. Inflammatory Bowel Diseases.
Crossref
Crossref
Sara Gostoli, Francesco Ferrara, Ludovica Quintavalle, Sara Tommasino, Graziano Gigante, Maria Montecchiarini, Alessia Urgese, Francesco Guolo, Regina Subach, Angelica D’Oronzo, Annamaria Polifemo, Federica Buonfiglioli, Vincenzo Cennamo & Chiara Rafanelli. (2024) Four-year follow-up of psychiatric and psychosomatic profile in patients with Inflammatory Bowel Disease (IBD). BMC Psychology 12:1.
Crossref
Crossref
Andreas Stallmach & Martin Kreis. 2024. Therapie-Handbuch - Gastroenterologie und Hepatologie. Therapie-Handbuch - Gastroenterologie und Hepatologie
232
246
.
Nathan Constantine-Cooke, Karla Monterrubio-Gómez, Nikolas Plevris, Lauranne A.A.P. Derikx, Beatriz Gros, Gareth-Rhys Jones, Riccardo E. Marioni, Charlie W. Lees & Catalina A. Vallejos. (2023) Longitudinal Fecal Calprotectin Profiles Characterize Disease Course Heterogeneity in Crohn’s Disease. Clinical Gastroenterology and Hepatology 21:11, pages 2918-2927.e6.
Crossref
Crossref
Lizi M. Hegarty, Gareth-Rhys Jones & Calum C. Bain. (2023) Macrophages in intestinal homeostasis and inflammatory bowel disease. Nature Reviews Gastroenterology & Hepatology 20:8, pages 538-553.
Crossref
Crossref
Bernd Bokemeyer, Sandra Plachta‐Danielzik, Romina di Giuseppe, Ulf Helwig, Niels Teich, Carsten Schmidt, Petra Hartmann, Christina Sobotzki & Stefan Schreiber. (2023) Evaluation of a downstaging, bidirectional version of the Montreal classification of Crohn's disease: Analysis of 5‐year follow‐up data from the prospective BioCrohn study. Alimentary Pharmacology & Therapeutics 58:1, pages 35-47.
Crossref
Crossref
Ahmed A. Al-Fawzan, Sulaiman A. Al-Radhi, Ahmed S. Al-Omar, Nawaf H. Al-Mutiri, Ammar M. Al-Ammari, Mohammad El-Gohary, Amal N. Shamsan, Hamdan M. Al Shehri & Naif S. ALGhasab. (2023) A Study of the Epidemiology, Clinical, and Phenotypic Characteristics of Inflammatory Bowel Disease in the Northen-Central Region of Saudi Arabia. Diagnostics 13:13, pages 2135.
Crossref
Crossref
Teresa Hof, Robert Thimme & Peter Hasselblatt. (2023) Diversitätsfaktoren in der Gastroenterologie. DMW - Deutsche Medizinische Wochenschrift 148:09, pages 519-527.
Crossref
Crossref
Sabrina Schnur, Vanessa Wahl, Julia K. Metz, Jessica Gillmann, Fabian Hans, Katharina Rotermund, Ralf-Kilian Zäh, Dietmar A. Brück, Marc Schneider & Marius Hittinger. (2022) Inflammatory bowel disease addressed by Caco-2 and monocyte-derived macrophages: an opportunity for an in vitro drug screening assay. In vitro models 1:4-5, pages 365-383.
Crossref
Crossref
Alexis Sieber, Faten N. Aberra, Brittaney Bonhomme, Liam McKeever & James D. Lewis. (2022) Influence of Corticosteroid Use on Short- and Long-Term Outcomes of Biologic Therapy for Inflammatory Bowel Diseases. Digestive Diseases and Sciences 67:11, pages 5168-5176.
Crossref
Crossref
Alyyah Malick & Bo Shen. (2022) Endoscopic Treatment of Postoperative Bleeding, Bezoars, and Foreign Bodies. Gastrointestinal Endoscopy Clinics of North America 32:4, pages 829-843.
Crossref
Crossref
Julien D Schulberg, Emily K Wright, Bronte A Holt, Amy L Hamilton, Tom R Sutherland, Alyson L Ross, Sara Vogrin, Ashley M Miller, William C Connell, Mark Lust, Nik S Ding, Gregory T Moore, Sally J Bell, Edward Shelton, Britt Christensen, Peter De Cruz, Yuwei J Rong & Michael A Kamm. (2022) Intensive drug therapy versus standard drug therapy for symptomatic intestinal Crohn's disease strictures (STRIDENT): an open-label, single-centre, randomised controlled trial. The Lancet Gastroenterology & Hepatology 7:4, pages 318-331.
Crossref
Crossref
Choong Wui Cho, Myung-Won You, Chi Hyuk Oh, Chang Kyun Lee & Sung Kyoung Moon. (2022) Long-term Disease Course of Crohn’s Disease: Changes in Disease Location, Phenotype, Activities, and Predictive Factors. Gut and Liver 16:2, pages 157-170.
Crossref
Crossref
Andreas Sturm, Raja Atreya, Dominik Bettenworth, Bernd Bokemeyer, Axel Dignaß, Robert Ehehalt, Christoph Germer, Philip C. Grunert, Ulf Helwig, Klaus Herrlinger, Peter Kienle, Martin E. Kreis, Torsten Kucharzik, Jost Langhorst, Christian Maaser, Johann Ockenga, Claudia Ott, Britta Siegmund, Sebastian Zeißig & Andreas Stallmach. (2022) Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – August 2021 – AWMF-Registernummer: 021-004. Zeitschrift für Gastroenterologie 60:03, pages 332-418.
Crossref
Crossref
Emanuele Sinagra, Dario Raimondo, Salvatore Marco Iacopinelli, Francesca Rossi, Giuseppe Conoscenti, Maria Angela Di Maggio, Sergio Testai, Rita Alloro, Marta Marasà, Alberto Calandra, Claudia Costanza, Serena Cristofalo, Socrate Pallio, Marcello Maida, Ilaria Tarantino & Goffredo Arena. (2021) An Unusual Presentation of Crohn’s Disease Diagnosed Following Accidental Ingestion of Fruit Pits: Report of Two Cases and Review of the Literature. Life 11:12, pages 1415.
Crossref
Crossref
M. A. Niriella, I. K. Liyanage, S. K. Kodisinghe, A. P. De Silva, A. V. G. A. M. Jayatissa, N. M. M. Navarathne, R. K. Peiris, U. P. Kalubovila, S. R. Kumarasena, R. W. Jayasekara & H. J. de Silva. (2021) Changing phenotype, early clinical course and clinical predictors of inflammatory bowel disease in Sri Lanka: a retrospective, tertiary care-based, multi-centre study. BMC Gastroenterology 21:1.
Crossref
Crossref
Mikael Verdalle-Cazes, Cloé Charpentier, Coralie Benard, Luc-Marie Joly, Jean-Nicolas Dacher, Guillaume Savoye & Céline Savoye-Collet. (2021) Abdominopelvic CT-scan in emergency departments for patients with suspected complications of Crohn’s disease: a single tertiary center experience. BMC Emergency Medicine 21:1.
Crossref
Crossref
Tao Li, Lei Gao, Lei Cao, Zhen Guo, Wenwei Qian, Yi Yin, Yi Li & Weiming Zhu. (2021) Changes in disease behaviour and location and factor analysis in patients with Crohn’s disease undergoing repeated-resections. European Journal of Gastroenterology & Hepatology 33:1S, pages e555-e563.
Crossref
Crossref
Anjana Bali & Monika Rani. 2021. Crohn’s Disease Recent Advances. Crohn’s Disease Recent Advances.
Mirabella Zhao, Lóránt Gönczi, Peter L Lakatos & Johan Burisch. (2021) The Burden of Inflammatory Bowel Disease in Europe in 2020. Journal of Crohn's and Colitis 15:9, pages 1573-1587.
Crossref
Crossref
Bernd Bokemeyer, Ulrich Tappe & Arne Bokemeyer. (2021) Chronisch entzündliche Darmerkrankungen: Tipps für eine differenzierte Biologika-Auswahl. Deutsches Ärzteblatt Online.
Crossref
Crossref
Sanskriti Varma, Adam S. Faye, Adithya Kannan, Garrett Lawlor, Abhishek Verma, Jordan Axelrad & Daniel E. Freedberg. (2020) Patients with More Severe IBD Get Clostridioides difficile Rather than Clostridioides difficile Increasing the Severity of IBD. Digestive Diseases and Sciences 66:9, pages 3113-3123.
Crossref
Crossref
Jian Wan, Xuan Wang, Yujie Zhang, Xianmin Xue, Yani Li, Zhenzhen Liu, Shuang Han, Min Chen, Yan Nie, Yongquan Shi, Jie Liang & Kaichun Wu. (2021) 5-Aminosalicylic Acid Prevents Disease Behavior Progression and Intestinal Resection in Colonic and Ileocolonic Crohn’s Disease Patients: A Retrospective Study. Canadian Journal of Gastroenterology and Hepatology 2021, pages 1-8.
Crossref
Crossref
Henit Yanai, Idan Goren, Lihi Godny, Nitsan Maharshak, Yulia Ron, Irit Avni Biron, Haim Leibovitzh, Hagar Banai Eran, Maya Aharoni Golan, Keren Rabinowitz, Tomer Ziv Baran, Inbar Lavie, Karin Yadgar, Keren Zonensain, Uri Kopylov, Shomron Ben Horin, Rami Eliakim, Matti Waterman, Yehuda Chowers, Shay Ben-Shachar & Iris Dotan. (2021) Early Indolent Course of Crohn’s Disease in Newly Diagnosed Patients Is Not Rare and Possibly Predictable. Clinical Gastroenterology and Hepatology 19:8, pages 1564-1572.e5.
Crossref
Crossref
Sharif Yassin, Naomi Fliss Isakov, Yulia Ron, Nathaniel Aviv Cohen, Ayal Hirsch & Nitsan Maharshak. (2021) A watchful waiting approach for newly diagnosed Crohn’s disease patients with an inflammatory phenotype. International Journal of Colorectal Disease 36:4, pages 735-743.
Crossref
Crossref
Gadour Eyad & Hassan Zeinab. (2021) Systematic review and meta-analysis of drug induced liver injury secondary to biologic medications in inflammatory bowel disease. Annals of Clinical Gastroenterology and Hepatology 5:1, pages 005-012.
Crossref
Crossref
Julien D Schulberg, Emily K Wright, Bronte A Holt, Helen E Wilding, Amy L Hamilton, Alyson L Ross & Michael A Kamm. (2020) Efficacy of drug and endoscopic treatment of Crohn's disease strictures: A systematic review. Journal of Gastroenterology and Hepatology 36:2, pages 344-361.
Crossref
Crossref
Andreas Stallmach. 2021. Therapie-Handbuch - Gastroenterologie und Hepatologie. Therapie-Handbuch - Gastroenterologie und Hepatologie
234
247
.
Margret Alm, Viola Andresen, Christian Ell, Christiane Fibbe, Wolfgang Fischbach, Jutta Keller, PH. Frank Kipp, Andrea May, Stephan Miehlke, Rainer Porschen, Andreas Stallmach, Thomas Weinke, Niklas Aehling, Margret Alm, Viola Andresen, Daniel C. Baumgart, Franziska Bertram, Albrecht Böhlig, Catharina Bullmann, Johanna Carstensen, Marie de Greck, Wienke Ellerbeck, Giulia Enders, Christiane Fibbe, Wolfgang Fischbach, Korinna Fritz, Antonia Gaus, Laura Gottschalk, Kai Daniel Grandt, Utah-Maria Henniges, Toni Herta, Dorothea Jasper, Jutta Keller, Nina Kschowak, Konstantin Lang, Alina Lange, Peter Layer, Niels Liedtke, Janek Luttermann, Lida Mancke, Viola Sophie Meier, Ulrike Melle, Daniela Menge, Stefan Michaelis, Sara Nader, Tim-Alexander Niedergassel, Carsten Pachmann, Rainer Porschen, Solveig Rose, Ulrich Rosien, Martin Rössle, Melina Schellhorn, Oliver Schnell, Sebastian Schulz, Julian Siegel, Alexander Stein, Johannes Szuba, Sarah Teising, Stephanie Thiel, Julia Thomas-Morr, Henriette Tillmann, Friederike Todt, Rhea Veelken, Henrike von Schassen, Michael Wölfel, Susanna Wolf, Valentin Wolgast, Clara Wübbolding & Kathrin Zimmermann. 2021. Facharztwissen Gastroenterologie und Hepatologie. Facharztwissen Gastroenterologie und Hepatologie
301
336
.
Genyan Liu, Yuqiao Xu, Shiyang Pan, Weijuan Song, Jia Wang, Fei Jin, Zhenzhen Cai, Yi Zhang & Xiang Qian. 2021. Clinical Molecular Diagnostics. Clinical Molecular Diagnostics
511
552
.
Anthony Passarella, Prabhsharn Grewal & Raluca Vrabie. 2021. Inflammatory Bowel Disease. Inflammatory Bowel Disease
25
59
.
Maryam Alkhatry, Ahmad Al-Rifai, Vito Annese, Filippos Georgopoulos, Ahmad N Jazzar, Ahmed M Khassouan, Zaher Koutoubi, Rahul Nathwani, Mazen S Taha & Jimmy K Limdi. (2020) First United Arab Emirates consensus on diagnosis and management of inflammatory bowel diseases: A 2020 Delphi consensus. World Journal of Gastroenterology 26:43, pages 6710-6769.
Crossref
Crossref
Mattia Crespi, Pietro Dulbecco, Antonella De Ceglie & Massimo Conio. (2020) Strictures in Crohn’s Disease: From Pathophysiology to Treatment. Digestive Diseases and Sciences 65:7, pages 1904-1916.
Crossref
Crossref
M. Rottoli, M. Tanzanu, C. A. Manzo, M. L. Bacchi Reggiani, P. Gionchetti, F. Rizzello, L. Boschi & G. Poggioli. (2020) Strictureplasty for Crohn’s disease of the small bowel in the biologic era: long-term outcomes and risk factors for recurrence. Techniques in Coloproctology 24:7, pages 711-720.
Crossref
Crossref
Min Seob Kwak, Jae Myung Cha, Hyun Phil Shin, Jung Won Jeon & Jin Young Yoon. (2020) Development of a Novel Metagenomic Biomarker for Prediction of Upper Gastrointestinal Tract Involvement in Patients With Crohn’s Disease. Frontiers in Microbiology 11.
Crossref
Crossref
Julien D Schulberg, Emily K Wright, Bronte A Holt, Tom R Sutherland, Simon J Hume, Amy L Hamilton, Alyson L Ross, William C Connell, Steven J Brown, Mark Lust, Ashley M Miller, Sally J Bell & Michael A Kamm. (2019) Magnetic resonance enterography for predicting the clinical course of Crohn's disease strictures. Journal of Gastroenterology and Hepatology 35:6, pages 980-987.
Crossref
Crossref
David H. Kim, Kevin J. Chang, Kathryn J. Fowler, Brooks D. Cash, Evelyn M. Garcia, Avinash R. Kambadakone, Angela D. Levy, Peter S. Liu, Sharon E. Mace, Daniele Marin, Courtney Moreno, Christine M. Peterson, Jason A. Pietryga, Lilja Bjork Solnes, Stefanie Weinstein & Laura R. Carucci. (2020) ACR Appropriateness Criteria® Crohn Disease. Journal of the American College of Radiology 17:5, pages S81-S99.
Crossref
Crossref
Nina A. Saxena & Scott D. Lee. 2020. Encyclopedia of Gastroenterology. Encyclopedia of Gastroenterology
739
753
.
Adam Rahman, Vipul Jairath, Brian G. Feagan, Reena Khanna, Salimah Z. Shariff, Britney N. Allen, Krista Bray Jenkyn, Christopher Vinden, Jenny Jeyarajah, Mahmoud Mosli & Eric Benchimol. (2019) Declining hospitalisation and surgical intervention rates in patients with Crohn's disease: a population‐based cohort. Alimentary Pharmacology & Therapeutics 50:10, pages 1086-1093.
Crossref
Crossref
Léon Maggiori, Antoine Brouquet, Philippe Zerbib, Jérémie H. Lefevre, Quentin Denost, Adeline Germain, Eddy Cotte, Laura Beyer-Berjot, Nicolas Munoz-Bongrand, Véronique Desfourneaux, Amine Rahili, Jean-Pierre Duffas, Karine Pautrat, Christine Denet, Valérie Bridoux, Guillaume Meurette, Jean-Luc Faucheron, Jérome Loriau, Regis Souche, Eric VicautYves Panis & Stéphane Benoist. (2019) Penetrating Crohn Disease Is Not Associated With a Higher Risk of Recurrence After Surgery. Annals of Surgery 270:5, pages 827-834.
Crossref
Crossref
Timna Naftali, Lihi Bar-Lev Schleider, Fabiana Sklerovsky Benjaminov, Ido Lish, Fred M. Konikoff & Yehuda Ringel. (2019) Medical cannabis for inflammatory bowel disease: real-life experience of mode of consumption and assessment of side-effects. European Journal of Gastroenterology & Hepatology 31:11, pages 1376-1381.
Crossref
Crossref
Xiao-Wei Sun, Juan Wei, Zhao Yang, Xin-Xin Jin, Hai-Jun Wan, Bo-Si Yuan, Miao-Fang Yang, Jiong Liu & Fang-Yu Wang. (2019) Clinical Features and Prognosis of Crohn’s Disease with Upper Gastrointestinal Tract Phenotype in Chinese Patients. Digestive Diseases and Sciences 64:11, pages 3291-3299.
Crossref
Crossref
Andreas Stallmach, Bernd Bokemeyer, Ulf Helwig, Andreas Lügering, Niels Teich, Imma Fischer, Stefan Rath, Dorothee Lang & Carsten Schmidt. (2019) Predictive parameters for the clinical course of Crohn’s disease: development of a simple and reliable risk model. International Journal of Colorectal Disease 34:10, pages 1653-1660.
Crossref
Crossref
M. K. Vester-Andersen, H. C. Mirsepasi-Lauridsen, M. V. Prosberg, C. O. Mortensen, C. Träger, K. Skovsen, T. Thorkilgaard, C. Nøjgaard, I. Vind, K. A. Krogfelt, N. Sørensen, F. Bendtsen & A. M. Petersen. (2019) Increased abundance of proteobacteria in aggressive Crohn’s disease seven years after diagnosis. Scientific Reports 9:1.
Crossref
Crossref
Elham Rahme, Hacene Nedjar & Waqqas Afif. (2019) Cost of Refractory Crohn’s Disease Before and After Ustekinumab Utilization. Journal of the Canadian Association of Gastroenterology.
Crossref
Crossref
Andréa Maia Pimentel, Raquel Rocha & Genoile Oliveira Santana. (2019) Crohn’s disease of esophagus, stomach and duodenum. World Journal of Gastrointestinal Pharmacology and Therapeutics 10:2, pages 35-49.
Crossref
Crossref
Ji H. Hwang & Chang S. Yu. (2019) Depression and resilience in ulcerative colitis and Crohn's disease patients with ostomy. International Wound Journal 16:S1, pages 62-70.
Crossref
Crossref
Shintaro Sagami, Taku Kobayashi, Nao Kikkawa, Satoko Umeda, Masaru Nakano, Takahiko Toyonaga, Shinji Okabayashi, Ryo Ozaki & Toshifumi Hibi. (2019) Combination of colonoscopy and magnetic resonance enterography is more useful for clinical decision making than colonoscopy alone in patients with complicated Crohn's disease. PLOS ONE 14:2, pages e0212404.
Crossref
Crossref
J.-P. Ritz. (2019) Behandlungsstrategien beim therapierefraktären Morbus Crohn in der Primär- und RezidivsituationTreatment strategies for refractory Crohn’s disease in the primary and relapse situation. coloproctology 41:1, pages 22-29.
Crossref
Crossref
Min Hyung WooYoung Hoon ChoMin Ji SohnEun Joo LeeJu Whi KimJin Soo MoonJae Sung KoHyun-young Kim. (2019) Use of Anti-TNF Alpha Blockers Can Reduce Operation Rate and Lead to Growth Gain in Pediatric Crohn's Disease. Pediatric Gastroenterology, Hepatology & Nutrition 22:4, pages 358.
Crossref
Crossref
A. Stallmach & M. Kreis. 2019. Therapie-Handbuch. Therapie-Handbuch
196
208
.
Gaetano Luglio, Gianluca Cassese, Alfonso Amendola, Antonio Rispo, Francesco Maione & Giovanni Domenico De Palma. (2018) Novel Approaches to Ileocolic and Perianal Fistulising Crohn’s Disease. Gastroenterology Research and Practice 2018, pages 1-14.
Crossref
Crossref
Koji Uchiyama, Hisashi Kishi, Wataru Komatsu, Masanori Nagao, Shuji Ohhira & Gen Kobashi. (2018) Lipid and Bile Acid Dysmetabolism in Crohn’s Disease. Journal of Immunology Research 2018, pages 1-6.
Crossref
Crossref
Stéphane Nahon, Toulsie Ramtohul, Thierry Paupard, Mehdi Belhassan, Emeline Clair & Vered Abitbol. (2018) Evolution in clinical presentation of inflammatory bowel disease over time at diagnosis: a multicenter cohort study. European Journal of Gastroenterology & Hepatology 30:10, pages 1125-1129.
Crossref
Crossref
Max Reinshagen. (2018) Welche Patienten mit chronisch aktiver CED benötigen eine Biologikatherapie?. CME 15:10, pages 59-66.
Crossref
Crossref
Seong Ho Park, Byong Duk Ye, Tae Young Lee & Joel G. Fletcher. (2018) Computed Tomography and Magnetic Resonance Small Bowel Enterography. Gastroenterology Clinics of North America 47:3, pages 475-499.
Crossref
Crossref
Kata Szántó, Tibor Nyári, Anita Bálint, Renáta Bor, Ágnes Milassin, Mariann Rutka, Anna Fábián, Zoltán Szepes, Ferenc Nagy, Tamás Molnár & Klaudia Farkas. (2018) Biological therapy and surgery rates in inflammatory bowel diseases – Data analysis of almost 1000 patients from a Hungarian tertiary IBD center. PLOS ONE 13:7, pages e0200824.
Crossref
Crossref
Webber Pak Wo Chan, Fadi Mourad & Rupert WL Leong. (2018) Crohn's disease associated strictures. Journal of Gastroenterology and Hepatology 33:5, pages 998-1008.
Crossref
Crossref
Gary R Lichtenstein, Edward V Loftus, Kim L Isaacs, Miguel D Regueiro, Lauren B Gerson & Bruce E Sands. (2018) ACG Clinical Guideline: Management of Crohn's Disease in Adults. American Journal of Gastroenterology 113:4, pages 481-517.
Crossref
Crossref
Robert Hodgson, Matthew Walton, Mousumi Biswas, Teumzghi Mebrahtu & Nerys Woolacott. (2017) Ustekinumab for Treating Moderately to Severely Active Crohn’s Disease after Prior Therapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics 36:4, pages 387-398.
Crossref
Crossref
Anke Heida, Alie Dijkstra, Anneke Muller Kobold, John W Rossen, Angelika Kindermann, Freddy Kokke, Tim de Meij, Obbe Norbruis, Rinse K Weersma, Margreet Wessels, Thalia Hummel, Johanna Escher, Herbert van Wering, Daniëlle Hendriks, Luisa Mearin, Henk Groen, Henkjan J Verkade & Patrick F van Rheenen. (2018) Efficacy of Home Telemonitoring versus Conventional Follow-up: A Randomized Controlled Trial among Teenagers with Inflammatory Bowel Disease. Journal of Crohn's and Colitis 12:4, pages 432-441.
Crossref
Crossref
B Lo, M K Vester-Andersen, I Vind, M Prosberg, M Dubinsky, C A Siegel, F Bendtsen & J Burisch. (2018) Changes in Disease Behaviour and Location in Patients With Crohn’s Disease After Seven Years of Follow-Up: A Danish Population-based Inception Cohort. Journal of Crohn's and Colitis 12:3, pages 265-272.
Crossref
Crossref
Max Reinshagen. (2018) Welche Patienten mit chronisch aktiver CED benötigen eine Biologikatherapie?. Gastro-News 5:1, pages 26-33.
Crossref
Crossref
Leonardo Guizzetti, Guangyong Zou, Reena Khanna, Parambir S Dulai, William J Sandborn, Vipul Jairath & Brian G Feagan. (2018) Development of Clinical Prediction Models for Surgery and Complications in Crohn’s Disease. Journal of Crohn's and Colitis 12:2, pages 167-177.
Crossref
Crossref
Aida Kapic Lunder, Jørgen Jahnsen, Linda Tøften Bakstad, Arne Borthne, Johannes Roksund Hov, Morten Vatn, Anne Negård, Bjørn Moum, Inger Camilla Solberg, Tomm Bernklev, Ole Høie, Magne Henriksen, Marte Lie Høivik, Øistein Hovde, Gert Huppertz-Hauss & Iril Monstad. (2018) Bowel Damage in Patients With Long-term Crohn’s Disease, Assessed by Magnetic Resonance Enterography and the Lémann Index. Clinical Gastroenterology and Hepatology 16:1, pages 75-82.e5.
Crossref
Crossref
A. Stallmach & M. Kreis. 2018. Therapie-Handbuch. Therapie-Handbuch
361
372
.
Xian-rui Wu & Bo Shen. 2018. Interventional Inflammatory Bowel Disease: Endoscopic Management and Treatment of Complications. Interventional Inflammatory Bowel Disease: Endoscopic Management and Treatment of Complications
309
317
.
Satimai Aniwan, Sang Hyoung Park & Edward V. LoftusJr.Jr.. (2017) Epidemiology, Natural History, and Risk Stratification of Crohn's Disease. Gastroenterology Clinics of North America 46:3, pages 463-480.
Crossref
Crossref
Kátia Simone Cezário de Barros, Cristina Flores, Luciana Harlacher & Carlos Fernando Magalhães Francesconi. (2017) Evolution of Clinical Behavior in Crohn’s Disease: Factors Associated with Complicated Disease and Surgery. Digestive Diseases and Sciences 62:9, pages 2481-2488.
Crossref
Crossref
Yoo Min Han, Jaemoon Koh, Ji Won Kim, Changhyun Lee, Seong-Joon Koh, ByeongGwan Kim, Kook Lae Lee, Jong Pil Im & Joo Sung Kim. (2017) NF-kappa B activation correlates with disease phenotype in Crohn’s disease. PLOS ONE 12:7, pages e0182071.
Crossref
Crossref
JJ Barlow & AB Hawthorne. (2017) Crohn's disease for the general physician: presentation and investigations. British Journal of Hospital Medicine 78:2, pages 72-76.
Crossref
Crossref
Yu Nishida, Shuhei Hosomi, Hirokazu Yamagami, Tomomi Yukawa, Yasuaki Nagami, Fumio Tanaka, Noriko Kamata, Tetsuya Tanigawa, Masatsugu Shiba, Toshio Watanabe, Kazunari Tominaga, Yasuhiro Fujiwara & Tetsuo Arakawa. (2017) Analysis of the Risk Factors of Surgery after Endoscopic Balloon Dilation for Small Intestinal Strictures in Crohn's Disease Using Double-balloon Endoscopy. Internal Medicine 56:17, pages 2245-2252.
Crossref
Crossref
Kari Skrautvol & Dagfinn Nåden. (2017) Tolerance Limits, Self-understanding, and Stress Resilience in Integrative Recovery of Inflammatory Bowel Disease. Holistic Nursing Practice 31:1, pages 30-41.
Crossref
Crossref
Charles N. Bernstein. 2017. Crohn's Disease and Ulcerative Colitis. Crohn's Disease and Ulcerative Colitis
301
309
.
Katrine Carlsen, Pia Munkholm & Johan Burisch. 2017. Crohn's Disease and Ulcerative Colitis. Crohn's Disease and Ulcerative Colitis
279
289
.
Klaudia Farkas, Heyson Chan, Mariann Rutka, Zoltán Szepes, Ferenc Nagy, László Tiszlavicz, Tibor Nyári, Whitney Tang, Grace Wong, Raymond Tang, Angeline Lo, Christina Cheung, Sunny Wong, Rashid Lui, Tamás Molnár & Siew C Ng. (2016) Gastroduodenal Involvement in Asymptomatic Crohn’s Disease Patients in Two Areas of Emerging Disease: Asia and Eastern Europe. Journal of Crohn's and Colitis 10:12, pages 1401-1406.
Crossref
Crossref
Øistein Hovde, Marte Lie Høivik, Magne Henriksen, Inger Camilla Solberg, Milada Cvancarova Småstuen & Bjørn A. Moum. (2016) Malignancies in Patients with Inflammatory Bowel Disease: Results from 20 Years of Follow-up in the IBSEN Study. Journal of Crohn's and Colitis, pages jjw193.
Crossref
Crossref
Fernando T. Veloso. (2016) Clinical predictors of Crohn’s disease course. European Journal of Gastroenterology & Hepatology 28:10, pages 1122-1125.
Crossref
Crossref
Ashwin N. Ananthakrishnan, Hai Yun Shi, Whitney Tang, Cindy C. Y. Law, Joseph J. Y. Sung, Francis K. L. Chan & Siew C. Ng. (2016) Systematic Review and Meta-analysis: Phenotype and Clinical Outcomes of Older-onset Inflammatory Bowel Disease. Journal of Crohn's and Colitis 10:10, pages 1224-1236.
Crossref
Crossref
Hanna Ribbing Wilén, Per-Olof Nyström, Leif Törkvist & Johannes Blom. (2016) Clinical and inflammatory response to first ileocolic resection for Crohn’s disease. European Surgery 48:4, pages 209-214.
Crossref
Crossref
Gert Huppertz-Hauss, Marte Lie Høivik, Lars-Petter Jelsness-Jørgensen, Magne Henriksen, Ole Høie, Jørgen Jahnsen, Geir Hoff, Bjørn Moum & Tomm Bernklev. (2016) Health-related Quality of Life in Patients with Inflammatory Bowel Disease 20 Years After Diagnosis. Inflammatory Bowel Diseases 22:7, pages 1679-1687.
Crossref
Crossref
Aranzazu Jauregui Amezaga & Gert Van Assche. (2016) Practical Approaches to “Top–Down” Therapies for Crohn’s Disease. Current Gastroenterology Reports 18:7.
Crossref
Crossref
Lynsey Stevenson. (2016) How to Improve Your Success in Treating Mild and Moderate Inflammatory Bowel Disease. EMJ Gastroenterology, pages 2-9.
Crossref
Crossref
Toshihiro Inokuchi, Jun Kato, Sakiko Hiraoka, Shiho Takashima, Asuka Nakarai, Daisuke Takei, Yuusaku Sugihara, Masahiro Takahara, Seiji Kawano, Keita Harada & Hiroyuki Okada. (2016) Fecal Immunochemical Test Versus Fecal Calprotectin for Prediction of Mucosal Healing in Crohnʼs Disease. Inflammatory Bowel Diseases 22:5, pages 1078-1085.
Crossref
Crossref
Tomer Greener, Eyal Klang, Doron Yablecovitch, Adi Lahat, Sandra Neuman, Nina Levhar, Benjamin Avidan, Henit Yanai, Iris Dotan, Yehuda Chowers, Batya Weiss, Fred Saibil, Marianne M. Amitai, Shomron Ben-Horin, Uri Kopylov & Rami Eliakim. (2016) The Impact of Magnetic Resonance Enterography and Capsule Endoscopy on the Re-classification of Disease in Patients with Known Crohn’s Disease: A Prospective Israeli IBD Research Nucleus (IIRN) Study. Journal of Crohn's and Colitis 10:5, pages 525-531.
Crossref
Crossref
Sanchit Bhasin, Harminder Singh, Laura E. Targownik, Eran Israeli & Charles N. Bernstein. (2016) Rates and Reasons for Nonuse of Prescription Medication for Inflammatory Bowel Disease in a Referral Clinic. Inflammatory Bowel Diseases 22:4, pages 919-924.
Crossref
Crossref
Peter Bossuyt & Séverine Vermeire. (2016) Treat to Target in Inflammatory Bowel Disease. Current Treatment Options in Gastroenterology 14:1, pages 61-72.
Crossref
Crossref
Elisa Liverani. (2016) How to predict clinical relapse in inflammatory bowel disease patients. World Journal of Gastroenterology 22:3, pages 1017.
Crossref
Crossref
Marley Ribeiro Feitosa, Omar Féres Filho, Camila Mussolin Tamaki, Camila Perazzoli, Mário Vinícius Angelete Alvarez Bernardes, Rogério Serafim Parra, José Joaquim Ribeiro da Rocha & Omar Féres. (2016) Adjunctive Hyperbaric Oxygen Therapy promotes successful healing in patients with refractory Crohn's disease. Acta Cirurgica Brasileira 31:suppl 1, pages 19-23.
Crossref
Crossref
Siew C. Ng, Zhirong Zeng, Ola Niewiadomski, Whitney Tang, Sally Bell, Michael A. Kamm, Pinjin Hu, H. Janaka de Silva, Madunil A. Niriella, W.S.A.A. Yasith Udara, David Ong, Khoon Lin Ling, Choon Jin Ooi, Ida Hilmi, Khean Lee Goh, Qin Ouyang, Yu Fang Wang, Kaichun Wu, Xin Wang, Pises Pisespongsa, Sathaporn Manatsathit, Satimai Aniwan, Julajak Limsrivilai, Jeffri Gunawan, Marcellus Simadibrata, Murdani Abdullah, Steve W.C. Tsang, Fu Hang Lo, Aric J. Hui, Chung Mo Chow, Hon Ho Yu, Mo Fong Li, Ka Kei Ng, Jessica Y.L. Ching, Victor Chan, Justin C.Y. Wu, Francis K.L. Chan, Minhu Chen & Joseph J.Y. Sung. (2016) Early Course of Inflammatory Bowel Disease in a Population-Based Inception Cohort Study From 8 Countries in Asia and Australia. Gastroenterology 150:1, pages 86-95.e3.
Crossref
Crossref
F. Obermeier & F. Klebl. 2016. Proktologische Diagnostik. Proktologische Diagnostik
111
125
.
Marta Mazza, Maria Giovanna Cilluffo & Maria Cappello. 2016. Crohn’s Disease. Crohn’s Disease
7
14
.
Gil Y. Melmed & Stephan R. Targan. 2015. Yamada' s Textbook of Gastroenterology. Yamada' s Textbook of Gastroenterology
1418
1449
.
Eun Soo Kim, Kyung Sik Park, Kwang Bum Cho, Kyeong Ok Kim, Byung Ik Jang, Eun Young Kim, Jin Tae Jung, Seong Woo Jeon, Min Kyu Jung, Hyun Seok Lee, Chang Heon Yang & Yong Kook Lee. (2015) Development of a Web-based, self-reporting symptom diary for Crohn's Disease, and its correlation with the Crohn's Disease Activity Index. Journal of Crohn's and Colitis, pages j.crohns.2014.09.003.
Crossref
Crossref
David H. Kim, Laura R. Carucci, Mark E. Baker, Brooks D. Cash, Jonathan R. Dillman, Barry W. Feig, Kathryn J. Fowler, Kenneth L. Gage, Richard B. Noto, Martin P. Smith, Vahid Yaghmai, Judy Yee & Tasneem Lalani. (2015) ACR Appropriateness Criteria Crohn Disease. Journal of the American College of Radiology 12:10, pages 1048-1057.e4.
Crossref
Crossref
Dessalegn Y. Melesse, Laura E. Targownik, Harminder Singh, James F. Blanchard & Charles N. Bernstein. (2015) Patterns and Predictors of Long-term Nonuse of Medical Therapy Among Persons with Inflammatory Bowel Disease. Inflammatory Bowel Diseases 21:7, pages 1615-1622.
Crossref
Crossref
Jianfeng Cheng. (2015) Analysis of Epidemiological and Clinical Characteristics of Inflammatory Bowel Disease over 15- year period. Gastroenterology & Hepatology : Open Access 2:3.
Crossref
Crossref
Petter Malmborg, Lena Grahnquist, Maja Ideström, Johan Lindholm, Ragnar Befrits, Jan Björk, Scott Montgomery & Hans Hildebrand. (2015) Presentation and Progression of Childhood-Onset Inflammatory Bowel Disease in Northern Stockholm County. Inflammatory Bowel Diseases 21:5, pages 1098-1108.
Crossref
Crossref
Gert Huppertz-Hauss, Marte Lie Høivik, Ebbe Langholz, Selwyn Odes, Milada Småstuen, Reinhold Stockbrugger, Geir Hoff, Bjørn Moum & Tomm Bernklev. (2015) Health-related Quality of Life in Inflammatory Bowel Disease in a European-wide Population-based Cohort 10 Years After Diagnosis. Inflammatory Bowel Diseases 21:2, pages 337-344.
Crossref
Crossref
Kari Skrautvol & Dagfinn Nåden. (2015) Nutrition as Long-term Care as Experienced by Persons Living With Inflammatory Bowel Disease. Holistic Nursing Practice 29:1, pages 22-32.
Crossref
Crossref
A. Stallmach & M. Kreis. 2015. Therapie-Handbuch Grundwerk inkl 6. Lfg.. Therapie-Handbuch Grundwerk inkl 6. Lfg.
1
12
.
Darina Kohoutova, Marcela Drahosova, Paula Moravkova, Stanislav Rejchrt & Jan Bures. (2014) Anti-Outer membrane protein C and anti-glycoprotein 2 antibodies in inflammatory bowel disease and their association with complicated forms of Crohn’s disease. BMC Gastroenterology 14:1.
Crossref
Crossref
Marianne K. Vester-Andersen, Ida Vind, Michelle V. Prosberg, Bo G. Bengtsson, Thomas Blixt, Pia Munkholm, Mikael Andersson, Tine Jess & Flemming Bendtsen. (2014) Hospitalisation, surgical and medical recurrence rates in inflammatory bowel disease 2003–2011—A Danish population-based cohort study. Journal of Crohn's and Colitis 8:12, pages 1675-1683.
Crossref
Crossref
Charlène Duchesne, Patrick Faure, François Kohler, Marie-Pierre Pingannaud, Guillaume Bonnaud, Franck Devulder, Laurent Abramowitz, Christian Boustière & Laurent Peyrin-Biroulet. (2014) Management of inflammatory bowel disease in France: A nationwide survey among private gastroenterologists. Digestive and Liver Disease 46:8, pages 675-681.
Crossref
Crossref
Fernando Magro, Eduardo Rodrigues-Pinto, Rosa Coelho, Patrícia Andrade, João Santos-Antunes, Susana Lopes, Claudia Camila-Dias & Guilherme Macedo. (2014) Is it Possible to Change Phenotype Progression in Crohn's Disease in the Era of Immunomodulators? Predictive Factors of Phenotype Progression. American Journal of Gastroenterology 109:7, pages 1026-1036.
Crossref
Crossref
Marianne K Vester-Andersen, Michelle V Prosberg, Tine Jess, Mikael Andersson, Bo G Bengtsson, Thomas Blixt, Pia Munkholm, Flemming Bendtsen & Ida Vind. (2014) Disease Course and Surgery Rates in Inflammatory Bowel Disease: A Population-Based, 7-Year Follow-Up Study in the Era of Immunomodulating Therapy. American Journal of Gastroenterology 109:5, pages 705-714.
Crossref
Crossref
Angelika Hueppe, Jana Langbrandtner & Heiner Raspe. (2014) Inviting Patients with Inflammatory Bowel Disease to Active Involvement in Their Own Care. Inflammatory Bowel Diseases, pages 1.
Crossref
Crossref
S. Schreiber & O. Bachmann. (2014) Neue Biologika für die Behandlung chronisch-entzündlicher DarmerkrankungenNew biologics for treatment of chronic inflammatory bowel diseases. Der Internist 55:4, pages 367-376.
Crossref
Crossref
Gordon W. Moran, Marie–France Dubeau, Gilaad G. Kaplan, Hong Yang, Cynthia H. Seow, Richard N. Fedorak, Levinus A. Dieleman, Herman W. Barkema, Subrata Ghosh & Remo Panaccione. (2014) Phenotypic Features of Crohn's Disease Associated With Failure of Medical Treatment. Clinical Gastroenterology and Hepatology 12:3, pages 434-442.e1.
Crossref
Crossref
Charlène Duchesne, Patrick Faure, François Kohler, Marie-Pierre Pingannaud, Guillaume Bonnaud, Franck Devulder, Laurent Abramowitz, Christian Boustière, Laurent Peyrin-Biroulet & CREGG. (2014) Prise en charge des patients atteints de maladie inflammatoire chronique intestinale en France : une enquête nationale auprès des gastro-entérologues libéraux. Hegel N° 1:1, pages 12-21.
Crossref
Crossref
Bjørn Moum, Øistein Hovde & Marte Lie Høivik. (2014) What Have We Learnt about the Role of the Environment and Natural Course of IBD in the New Millennium? 20-Year Follow-Up of the IBSEN Cohort. Digestive Diseases 32:Suppl. 1, pages 2-9.
Crossref
Crossref
Eugeni Domènech, Míriam Mañosa & Eduard Cabré. (2014) An Overview of the Natural History of Inflammatory Bowel Diseases. Digestive Diseases 32:4, pages 320-327.
Crossref
Crossref
Inger C. Solberg, Milada Cvancarova, Morten H. Vatn & Bjørn Moum. (2014) Risk Matrix for Prediction of Advanced Disease in a Population-based Study of Patients with Crohnʼs Disease (the IBSEN Study). Inflammatory Bowel Diseases 20:1, pages 60-68.
Crossref
Crossref
Alexandra D. Frolkis, Jonathan Dykeman, María E. Negrón, Jennifer deBruyn, Nathalie Jette, Kirsten M. Fiest, Talia Frolkis, Herman W. Barkema, Kevin P. Rioux, Remo Panaccione, Subrata Ghosh, Samuel Wiebe & Gilaad G. Kaplan. (2013) Risk of Surgery for Inflammatory Bowel Diseases Has Decreased Over Time: A Systematic Review and Meta-analysis of Population-Based Studies. Gastroenterology 145:5, pages 996-1006.
Crossref
Crossref
Marian D. Pfefferkorn, Francis E. Marshalleck, Shehzad A. Saeed, Judy B. Splawski, Bradley C. Linden & Benjamin F. Weston. (2013) NASPGHAN Clinical Report on the Evaluation and Treatment of Pediatric Patients With Internal Penetrating Crohn Disease. Journal of Pediatric Gastroenterology and Nutrition 57:3, pages 394-400.
Crossref
Crossref
Veerle J. A. A. Nuij, Zuzana Zelinkova, Marno C. M. Rijk, Ruud Beukers, Rob J. T. Ouwendijk, Rutger Quispel, Antonie J. P. van Tilburg, Thjon J. Tang, Hermen Smalbraak, Karlien F. Bruin, Flordeliz Lindenburg, Laurent Peyrin-Biroulet & C. Janneke van der Woude. (2013) Phenotype of Inflammatory Bowel Disease at Diagnosis in the Netherlands. Inflammatory Bowel Diseases 19:10, pages 2215-2222.
Crossref
Crossref
W. Kruis, A. Katalinic, T. Klugmann, G.-R. Franke, J. Weismüller, L. Leifeld, S. Ceplis-Kastner, B. Reimers & B. Bokemeyer. (2013) Predictive factors for an uncomplicated long-term course of Crohn's disease: A retrospective analysis. Journal of Crohn's and Colitis 7:7, pages e263-e270.
Crossref
Crossref
Ioannis E KoutroubakisMathurin FumeryJean-Louis DupasPierre Desreumaux. 2013. Advances in the Management of Inflammatory Bowel Disease. Advances in the Management of Inflammatory Bowel Disease
158
172
.
Yoon Suk Jung, Jae Hee Cheon, Soo Jung Park, Sung Pil Hong, Tae Il Kim & Won Ho Kim. (2012) Clinical Course of Intestinal Behcet’s Disease During the First Five Years. Digestive Diseases and Sciences 58:2, pages 496-503.
Crossref
Crossref
Valerie Pittet, Gerhard Rogler, Pierre Michetti, Nicolas Fournier, John-Paul Vader, Alain Schoepfer, Christian Mottet, Bernard Burnand & Florian Froehlich. (2013) Penetrating or Stricturing Diseases are the Major Determinants of Time to First and Repeat Resection Surgery in Crohn's Disease. Digestion 87:3, pages 212-221.
Crossref
Crossref
Gerhard Rogler. (2013) Top-Down or Step-Up Treatment in Crohn's Disease?. Digestive Diseases 31:1, pages 83-90.
Crossref
Crossref
Lani Prideaux, Peter De Cruz, Siew C. Ng & Michael A. Kamm. (2012) Serological Antibodies in Inflammatory Bowel Disease: A Systematic Review. Inflammatory Bowel Diseases 18:7, pages 1340-1355.
Crossref
Crossref
Marte Lie Høivik, Tomm Bernklev, Inger Camilla Solberg, Milada Cvancarova, Idar Lygren, Jørgen Jahnsen & Bjørn Moum. (2012) Patients with Crohn's disease experience reduced general health and vitality in the chronic stage: Ten-year results from the IBSEN study. Journal of Crohn's and Colitis 6:4, pages 441-453.
Crossref
Crossref
S. Marques, J. Garcia-Gonzalo, B. Botequim, A. Ricardo, J.G. Borges, M. Tome & M.M. Oliveira. (2012) Assessing wildfire occurrence probability in Pinus pinaster Ait. stands in Portugal. Forest Systems 21:1, pages 111.
Crossref
Crossref
Sandra Wenger, Susanna Nikolaus, Stefanie Howaldt, Bernd Bokemeyer, Andreas Sturm, Jan C. Preiss, Alain M. Schoepfer, Andreas Stallmach & Carsten Schmidt. (2012) Predictors for subsequent need for immunosuppressive therapy in early Crohn's disease. Journal of Crohn's and Colitis 6:1, pages 21-28.
Crossref
Crossref
Assar A. Rather & Eric G. Weiss. 2012. The SAGES Manual. The SAGES Manual
515
530
.
Charles N. Bernstein. 2012. Crohn's Disease and Ulcerative Colitis. Crohn's Disease and Ulcerative Colitis
343
363
.
Pia Munkholm & Natalia Pedersen. 2012. Crohn's Disease and Ulcerative Colitis. Crohn's Disease and Ulcerative Colitis
333
340
.
Kari Skrautvol & Dagfinn Nåden. (2011) Nutritional care in inflammatory bowel disease – a literature review. Scandinavian Journal of Caring Sciences 25:4, pages 818-827.
Crossref
Crossref
Michael A. Kamm, Siew C. Ng, Peter De Cruz, Patrick Allen & Stephen B. Hanauer. (2011) Practical application of anti-TNF therapy for luminal Crohnʼs disease. Inflammatory Bowel Diseases 17:11, pages 2366-2391.
Crossref
Crossref
K. Elriz, V. Palascak-Juif, F. Joly, D. Seguy, P. Beau, C. Chambrier, M. Boncompain, E. Fontaine, D. Laharie, G. Savoye & E. Lerebours. (2011) Crohn’s disease patients with chronic intestinal failure receiving long-term parenteral nutrition: a cross-national adult study. Alimentary Pharmacology & Therapeutics 34:8, pages 931-940.
Crossref
Crossref
A. Qasim, N. Ullah, P. Crotty, N. Swan, N. Breslin, B. Ryan, W. Torreggiani, E. Eguare, P. Neary, H. O’Connor & C. O’Morain. (2011) A changing trend in the management of patients with newly diagnosed Crohn’s disease. Irish Journal of Medical Science 180:3, pages 643-647.
Crossref
Crossref
Anne Prenzler, Bernd Bokemeyer, J.-Matthias von der Schulenburg & Thomas Mittendorf. (2010) Health care costs and their predictors of inflammatory bowel diseases in Germany. The European Journal of Health Economics 12:3, pages 273-283.
Crossref
Crossref
Milada Mahic, Svetlana Skurtveit, Randi Selmer, Marit Rønning & Kari Furu. (2010) Prevalence, incidence and persistence of etanercept and adalimumab in Norway 2005–2009. Pharmacoepidemiology and Drug Safety 20:5, pages 457-463.
Crossref
Crossref
Vincenzo Migaleddu, Emilio Quaia, Domenico Scanu, Serra Carla, Michele Bertolotto, Girolamo Campisi, Danilo Sirigu & Giuseppe Virgilio. (2010) Inflammatory activity in Crohn’s disease: CE-US. Abdominal Imaging 36:2, pages 142-148.
Crossref
Crossref
Benjamin Pariente & Yoram Bouhnik. 2011. Post’U FMC-HGE. Post’U FMC-HGE
115
124
.
Laurent Peyrin-Biroulet. 2011. Post’U FMC-HGE. Post’U FMC-HGE
105
114
.
Stefan Schreiber, Jean-Frédéric Colombel, Ralph Bloomfield, Susanna Nikolaus, Jürgen Schölmerich, Julian Panés & William J Sandborn. (2010) Increased Response and Remission Rates in Short-Duration Crohn's Disease With Subcutaneous Certolizumab Pegol: An Analysis of PRECiSE 2 Randomized Maintenance Trial Data. American Journal of Gastroenterology 105:7, pages 1574-1582.
Crossref
Crossref
Anis Ahmadi, Qin Li, Keith Muller, Dennis Collins, John F. Valentine, Walter Drane & Steven Polyak. (2010) Diagnostic value of noninvasive combined fluorine-18 labeled fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography enterography in active Crohnʼs disease. Inflammatory Bowel Diseases 16:6, pages 974-981.
Crossref
Crossref
Andreas Stallmach, Stefan Hagel & Tony Bruns. (2010) Adverse effects of biologics used for treating IBD. Best Practice & Research Clinical Gastroenterology 24:2, pages 167-182.
Crossref
Crossref
Laurent Peyrin-Biroulet, Edward V Loftus, Jean-Frederic Colombel & William J Sandborn. (2010) The Natural History of Adult Crohn's Disease in Population-Based Cohorts. American Journal of Gastroenterology 105:2, pages 289-297.
Crossref
Crossref
Su Jin JeonKwang Jae LeeMyung Hee LeeSeon Kyo LimChang Jun KangJin Hong Kim. (2010) Rates of Early Surgery and Associated Risk Factors in Crohn's Disease. The Korean Journal of Gastroenterology 56:4, pages 236.
Crossref
Crossref
Shuichiro Takahashi, Sho Takagi, Hisashi Shiga, Ken Umemura, Katuya Endo, Yoichi Kakuta, Seiichi Takahashi, Yoshitaka Kinouchi & Tooru Shimosegawa. (2010) Scheduled Maintenance Therapy with Infliximab Improves the Prognosis of Crohn's Disease: A Single Center Prospective Cohort Study in Japan. The Tohoku Journal of Experimental Medicine 220:3, pages 207-215.
Crossref
Crossref
Fernando Magro, Francisco Portela, Paula Lago, João Ramos de Deus, Ana Vieira, Paula Peixe, Isabelle Cremers, José Cotter, Marília Cravo, Lourdes Tavares, Jorge Reis, Raquel Gonçalves, Horácio Lopes, Paulo Caldeira, Paula Ministro, Laura Carvalho, Luis Azevedo & Altamiro Da Costa-Pereira. (2009) Crohnʼs disease in a southern European country: Montreal classification and clinical activity. Inflammatory Bowel Diseases 15:9, pages 1343-1350.
Crossref
Crossref
Laurent Peyrin-Biroulet & Jean-Frederic Colombel. (2009) Natural history—an optimistic message from Norway. Nature Reviews Gastroenterology & Hepatology 6:7, pages 387-388.
Crossref
Crossref
Debra J. Helper. (2009) Medical management of Crohn's disease: A guide for radiologists. European Journal of Radiology 69:3, pages 371-374.
Crossref
Crossref
M J L Romberg-Camps, P C Dagnelie, A D M Kester, M A M Hesselink-van de Kruijs, M Cilissen, L G J B Engels, C Van Deursen, W H A Hameeteman, F L Wolters, M G V M Russel & R W Stockbrügger. (2009) Influence of Phenotype at Diagnosis and of Other Potential Prognostic Factors on the Course of Inflammatory Bowel Disease. The American Journal of Gastroenterology 104:2, pages 371-383.
Crossref
Crossref
Brian G. Feagan, Remo Panaccione, William J. Sandborn, Geert R. D'Haens, Stefan Schreiber, Paul J. Rutgeerts, Edward V. LoftusJrJr, Kathleen G. Lomax, Andrew P. Yu, Eric Q. Wu, Jingdong Chao & Parvez Mulani. (2008) Effects of Adalimumab Therapy on Incidence of Hospitalization and Surgery in Crohn's Disease: Results From the CHARM Study. Gastroenterology 135:5, pages 1493-1499.
Crossref
Crossref
Johan Van Limbergen, Richard K. Russell, Hazel E. Drummond, Marian C. Aldhous, Nicola K. Round, Elaine R. Nimmo, Linda Smith, Peter M. Gillett, Paraic McGrogan, Lawrence T. Weaver, W. Michael Bisset, Gamal Mahdi, Ian D. Arnott, Jack Satsangi & David C. Wilson. (2008) Definition of Phenotypic Characteristics of Childhood-Onset Inflammatory Bowel Disease. Gastroenterology 135:4, pages 1114-1122.
Crossref
Crossref
Mahmood Zamirian & Amir Aslani. (2008) Response to Dr. Ze-Zhou Song. The American Journal of Gastroenterology 103:1, pages 241-241.
Crossref
Crossref
J. Schölmerich. 2008. IBD 2007 — Achievements in Research and Clinical Practice. IBD 2007 — Achievements in Research and Clinical Practice
232
242
.
Selwyn Odes, Hillel Vardi, Michael Friger, Frank Wolters, Ole Hoie, Bjørn Moum, Tomm Bernklev, Hagit Yona, Maurice Russel, Pia Munkholm, Ebbe Langholz, Lene Riis, Patrizia Politi, Paolo Bondini, Epameinondas Tsianos, Kostas Katsanos, Juan Clofent, Severine Vermeire, João Freitas, Iannis Mouzas, Charles Limonard, Colm O'Morain, Estela Monteiro, Giovanni Fornaciari, Morten Vatn & Reinhold Stockbrugger. (2007) Effect of phenotype on health care costs in Crohn’s disease: A European study using the Montreal classification. Journal of Crohn's and Colitis 1:2, pages 87-96.
Crossref
Crossref
Inger Camilla Solberg, Morten H. Vatn, Ole Høie, Njaal Stray, Jostein Sauar, Jørgen Jahnsen, Bjørn Moum & Idar Lygren. (2007) Clinical Course in Crohn’s Disease: Results of a Norwegian Population-Based Ten-Year Follow-Up Study. Clinical Gastroenterology and Hepatology 5:12, pages 1430-1438.
Crossref
Crossref
Andre da Luz Moreira, Luca Stocchi, Feza H. Remzi, Daniel Geisler, Jeffery Hammel & Victor W. Fazio. (2007) Laparoscopic Surgery for Patients with Crohn’s Colitis: A Case-matched Study. Journal of Gastrointestinal Surgery 11:11, pages 1529-1533.
Crossref
Crossref